Humira Injection 40mg/0,4ml

Key Uses

Humira is approved for treating a range of conditions in adults and children, often when other therapies have been ineffective:

• Arthritis: Rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and juvenile idiopathic arthritis.
• Inflammatory Bowel Disease: Crohn's disease and ulcerative colitis.
• Skin Conditions: Chronic plaque psoriasis and hidradenitis suppurativa (a painful skin disease).
• Eye Inflammation: Non-infectious uveitis (inflammation in parts of the eye).

Important Considerations

• Mechanism: The active ingredient, adalimumab, is a monoclonal antibody that blocks TNFα, an inflammatory protein.
• Administration: The medication is injected under the skin using a pre-filled syringe or pen, typically every other week, though dosing schedules vary by condition. A healthcare provider typically provides instructions on proper use.
• Side Effects: Common side effects include injection site reactions (pain, redness, rash), headaches, and respiratory infections. Serious infections, including tuberculosis and cancer, are potential rare but severe risks.
• Storage: Humira must be stored in the refrigerator between 2°C and 8°C (36°F and 46°F) in its original carton and should not be frozen.
• Prescription Only: This is a powerful prescription medication and should only be used as directed by a healthcare professional.

A patient should always inform their doctor about any existing health conditions, other medications they are taking, or if they are scheduled for surgery or vaccinations, as these may impact treatment.

Disclaimer: This information is for informational purposes only, and does not constitute medical advice. A healthcare professional should be consulted for any health concerns or before starting or stopping any medication.